SPONSOR
Jinling Hospital, China
Total Trials
3
Recruiting
3
Phases
Phase 2, EARLY_Phase 1
Conditions studied: CarcinomaUpper Tract Urothelial CarcinomaUTUCThe Efficacy of Biologics for Stricturing Crohn's DiseasesPancreatic Cancer
Jinling Hospital, China is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Carcinoma, Upper Tract Urothelial Carcinoma, UTUC, The Efficacy of Biologics for Stricturing Crohn's Diseases.
The trial portfolio spans Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jinling Hospital, China
How many clinical trials has Jinling Hospital, China sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Jinling Hospital, China, of which 3 are actively recruiting participants. These trials cover conditions including Carcinoma, Upper Tract Urothelial Carcinoma, UTUC. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jinling Hospital, China research focus on?
Jinling Hospital, China clinical trials span Carcinoma, Upper Tract Urothelial Carcinoma, UTUC, The Efficacy of Biologics for Stricturing Crohn's Diseases, Pancreatic Cancer. The research pipeline includes Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jinling Hospital, China clinical trial?
To participate in a Jinling Hospital, China trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jinling Hospital, China trials with current recruitment status updated daily.
Clinical Trials by Jinling Hospital, China
NCT05917158 Phase 2
Recruiting
A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma
Carcinoma
NCT05645055
Recruiting
Biologics for Stricturing Crohn's Diseases
The Efficacy of Biologics for Stricturing Crohn's Diseases
NCT06326736 EARLY_Phase 1
Recruiting
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
Pancreatic Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology